NASDAQ · Shell Companies · USD

Columbus Circle Capital Corp II (CMII) Stock Analysis

Columbus Circle Capital Corp II (CMII) is a Shell Companies stock listed on NASDAQ and quoted in US Dollar.

CMII

$10.05

$0.00 (0.00%)

Sep 3, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare CMII with… →

CMII Key Statistics

As of Sep 3, 2026

Trading

Open: $10.05
Previous Close: $10.05
Day's Range: 10.04–10.05
52-Week Range: 9.76–10.22
Volume: 2.79K

Valuation

Market Cap: $315.20M

Financials (FY)

Profit margin: 0.00%
Shares Outstanding: 23.66M

Dividend and dates

Avg Volume: 172.82K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

CMII Valuation vs Shell Companies Median

Median of 587 stocks

Metric	CMII	Shell Companies median	vs median
Profit margin	0.00%	0.00%	0.0 pts above

Medians across 587 Shell Companies stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

Columbus Circle Capital Corp II (CMII) carries a market capitalisation of $315.20M. The company sits in the Financial Services sector, in the Shell Companies industry.

Over the past 52 weeks the price has ranged from $9.76 to $10.22. CMII last closed at $10.05 on September 3, 2026. The close was unchanged from the previous session. The latest close sits 2.96% above that 52-week low.

Financial Health

The reported profit margin is 0%.

Valuation Assessment

The stored price history starts on February 27, 2026, and the total return since then is +2.40%.

Growth & Income

No dividend is on file for CMII.

So far in 2026 the price is +2.40%.

Peer Comparison

Columbus Circle Capital Corp II (CMII) operates in the Shell Companies industry. Here is how it compares to its closest peers by market capitalization:

Company	Ticker	Market Cap	P/E Ratio
Columbus Circle Capital Corp II	CMII	$315.20M	—
Churchill Capital Corp XI	CCXI	$746.38M	—
Churchill Capital Corp X	CCCX	$711.00M	—
Drugs Made In America Acquisition II Corp.	DMII	$647.83M	35.1

The Shell Companies industry average P/E ratio is 45.2x. Columbus Circle Capital Corp II has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 3, 2026.

Related Shell Companies Stocks

CCXI

Churchill Capital Corp XI

$746.38M

CCCX

Churchill Capital Corp X

$711.00M

DMII

Drugs Made In America Acquisition II Corp.

$647.83M

BCSS

Bain Capital GSS Investment Corp.

$602.40M

EVAC

EQV Ventures Acquisition Corp. II

$602.01M

CXII

Churchill Capital Corp XII

$594.94M

View all Shell Companies stocks →

Popular Financial Services Stocks

BRK-B

Berkshire Hathaway Inc.

$1.08T

JPM

JPMorgan Chase & Co.

$953.33B

Visa Inc.

$700.27B

Mastercard Incorporated

$507.39B

BAC

Bank of America Corporation

$438.31B

View all Financial Services stocks →

About Columbus Circle Capital Corp II

Inflection Point Acquisition Corp. VII does not have significant operations. It intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was formerly known as Columbus Circle Capital Corp II and changed its name to Inflection Point Acquisition Corp. VII in August 2026. The company was incorporated in 2025 and is based in New York, New York.